Evidence map›Paper›PMID 32646452›Full record

ArticleDiagnostic pathology2020

Deadly combination of Vaping-lnduced lung injury and Influenza: case report.

Bindu H Akkanti, Rahat Hussain, Manish K Patel, Jayeshkumar A Patel, Kha Dinh, Bihong Zhao, Shaimaa Elzamly, Kevin Pelicon, Klemen Petek, Ismael A Salas de Armas and 4 more

Erratum issuedAbstract readCase Reports
In one paragraph

Article in Diagnostic pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. E-cigarettes in the COVID-19 era.Annals of thoracic medicine
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Bindu H AkkantiDivisions of Pulmonary, Critical Care and Sleep Medicine, McGovern Medical School, Houston, TX, USA.
Rahat HussainDivisions of Pulmonary, Critical Care and Sleep Medicine, McGovern Medical School, Houston, TX, USA.
Manish K PatelAdvanced Cardio-Pulmonary Therapeutics and Transplantation, McGovern Medical School, Houston, TX, USA.
Jayeshkumar A PatelAdvanced Cardio-Pulmonary Therapeutics and Transplantation, McGovern Medical School, Houston, TX, USA.
Kha DinhDivisions of Pulmonary, Critical Care and Sleep Medicine, McGovern Medical School, Houston, TX, USA.
Bihong ZhaoDepartment of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), 6431 Fannin St. MSB 2.276, Houston, TX, 77030, USA.
Shaimaa ElzamlyDepartment of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), 6431 Fannin St. MSB 2.276, Houston, TX, 77030, USA.
Kevin PeliconAdvanced Cardio-Pulmonary Therapeutics and Transplantation, McGovern Medical School, Houston, TX, USA.
Klemen PetekAdvanced Cardio-Pulmonary Therapeutics and Transplantation, McGovern Medical School, Houston, TX, USA.
Ismael A Salas de ArmasAdvanced Cardio-Pulmonary Therapeutics and Transplantation, McGovern Medical School, Houston, TX, USA.
Mehmet AkayAdvanced Cardio-Pulmonary Therapeutics and Transplantation, McGovern Medical School, Houston, TX, USA.
Biswajit KarAdvanced Cardio-Pulmonary Therapeutics and Transplantation, McGovern Medical School, Houston, TX, USA.
Igor D GregoricAdvanced Cardio-Pulmonary Therapeutics and Transplantation, McGovern Medical School, Houston, TX, USA.
L Maximilian BujaDepartment of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), 6431 Fannin St. MSB 2.276, Houston, TX, 77030, USA. l.maximilian.buja@uth.tmc.edu.ORCID http://orcid.org/0000-0001-8386-7029

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundE-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping devices. Another consideration is that EVALI may have an adverse influence on the outcome of intercurrent respiratory infections. We document this deadly combination in the case of a young man who had EVALI and simultaneous 41 Influenza-A infection leading to severe Acute Respiratory Distress Syndrome (ARDS). CASE PRESENTATION: A 27-year-old male with a history of tobacco and vaping use was admitted to hospital after two weeks of flu-like symptoms, diarrhea and vomiting. A chest x-ray was consistent with multifocal pneumonia, and microbiological tests were positive for Influenza-A and methicillin-sensitive Staphalacoccus aureus (MSSA). Bronchoscopy provided evidence of acute inhalational injury. After admission, he acutely decompensated with severe hypoxia and hypotension; he required intubation, sedation and vasopressors. He developed sepsis with acute kidney failure, liver failure, biventricular systolic dysfunction and severe rhabdomyolysis. He was placed on veno-venous (VV) extracorporeal membrane oxygenation (ECMO) initially and later changed to Veno-Arterial (VA) ECMO. Nevertheless, the patient continued to deteriorate, and he expired two weeks after admission.

conclusionThis case documents that EVALI can act as a major factor leading a respiratory infection to progress into severe ARDS with a fatal outcome.

Indexed as

Acute Lung InjuryAdultElectronic Nicotine Delivery SystemsFatal OutcomeHumansInfluenza A virusInfluenza, HumanMaleRespiratory Distress SyndromeStaphylococcal InfectionsVapingAcute respiratory distress syndrome (ARDS)Case reportDiffuse alveolar damage (DAD)InfluenzaVaping

Identifiers

PMID32646452
PMCPMC7346855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.